Tidemark’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Tidemark’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$788	Buy	+5	New	+$789	﹤0.01%	876
2025 Q3	–	Sell	-108	Closed	-$8.99K	–	709
2025 Q2	$8.99K	Sell	108 -43	-28%	-$3.43K	﹤0.01%	462
2025 Q1	$12.2K	Sell	151 -45	-23%	-$4.02K	﹤0.01%	407
2024 Q4	$17.6K	Sell	196 -199	-50%	-$19.3K	0.01%	360
2024 Q3	$39.1K	Buy	395 +199	+102%	+$19.6K	0.02%	268
2024 Q2	$18.1K	Hold	196	–	–	0.01%	332
2024 Q1	$18.6K	Sell	196 -24	-11%	-$2.23K	0.01%	343
2023 Q4	$19.6K	Buy	+220	New	+$16.3K	0.01%	335

Other funds holding XBI

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $72.8B AUM 32.97% 1-Year Est. Return

Natixis Paris, France $28B AUM 27.03% 1-Year Est. Return

Employees Retirement System of Texas Austin, Texas $12.2B AUM 27.55% 1-Year Est. Return

Investure LLC Charlottesville, Virginia $1.83B AUM 14.32% 1-Year Est. Return

STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return

Tidemark's XBI Position: Q3 2026 in Review

Tidemark opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q3 2026: 5 shares worth $788. The stake represents ﹤0.01% of the portfolio and ranks #876 among its holdings. This is a return to the name: Tidemark previously reported a position in XBI as recently as Q2 2025.

Tidemark first reported a position in XBI in Q4 2023 and has held it in 8 quarters since. The position peaked at $39.1K in Q3 2024. 604 funds tracked by Wall St. Rank hold XBI as of Q3 2026.

Tidemark held 5 shares of State Street SPDR S&P Biotech ETF worth $788 as of Q3 2026.
State Street SPDR S&P Biotech ETF was a new Tidemark position in Q3 2026.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of Tidemark's portfolio in Q3 2026, its #876 holding.
Tidemark first reported a position in State Street SPDR S&P Biotech ETF in Q4 2023 and has held it in 8 quarters since.
Tidemark's State Street SPDR S&P Biotech ETF position peaked at $39.1K in Q3 2024.
604 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.

Based on Tidemark's 13F filing for Q3 2026, filed 9 Nov 2026.